Michael H. Bachmann

Advances in in vivo bioluminescence imaging of gene expression.

Sleep disturbances in women with metastatic breast cancer.

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.

Alternative therapies: a common practice among men and women living with HIV.

Shifting foci of hematopoiesis during reconstitution from single stem cells.

A genetic reporter of thermal stress defines physiologic zones over a defined temperature range.

Molecular medicine: the writing is on the vessel wall.

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation.

Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS.

In vivo analysis of heat-shock-protein-70 induction following pulsed laser irradiation in a transgenic reporter mouse.

CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy.

Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors.

Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector.

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models.

Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects.

A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages.

Functional imaging of legumain in cancer using a new quenched activity-based probe.

Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay.

A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.

Differential fates of biomolecules delivered to target cells via extracellular vesicles.